DR(high+)CD45RA(-)-Tregs potentially affect the suppressive activity of the total Treg pool in renal transplant patients.
about
Regulatory T Cells in Kidney Transplantation: New Directions?Nanotechnology as a New Therapeutic Approach to Prevent the HIV-Infection of Treg Cells.Central Role of CD45RA- Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation ToleranceCell therapy for immunosuppression after kidney transplantation.Regulatory T-cells and preeclampsia: an overview of literature.Cell therapeutic approaches to immunosuppression after clinical kidney transplantation.Overexpression of CD45RA isoforms in carriers of the C77G mutation leads to hyporeactivity of CD4+CD25highFoxp3+ regulatory T cells.The Leuven Immunomodulatory Protocol Promotes T-Regulatory Cells and Substantially Prolongs Survival After First Intestinal Transplantation.Large-scale in vitro expansion of human regulatory T cells with potent xenoantigen-specific suppression.Comprehensive phenotyping of regulatory T cells after liver transplantation.The extent of HLA-DR expression on HLA-DR(+) Tregs allows the identification of patients with clinically relevant borderline rejection.Phenotypic characterization of regulatory T cells populations in maternal blood, cord blood and placenta from diabetic mothers.Blood biomarkers of kidney transplant rejection, an endless search?Differentiation of ICOS+ and ICOS- recent thymic emigrant regulatory T cells (RTE T regs) during normal pregnancy, pre-eclampsia and HELLP syndrome.Human CD45RA(-) FoxP3(hi) Memory-Type Regulatory T Cells Show Distinct TCR Repertoires With Conventional T Cells and Play an Important Role in Controlling Early Immune Activation.The role of recent thymic emigrant-regulatory T-cell (RTE-Treg) differentiation during pregnancy.The role of regulatory T cell (Treg) subsets in gestational diabetes mellitus.
P2860
Q26800184-84A42B23-89A1-4A5C-ABB4-6A267F2C7BC7Q35897923-4D472B31-9537-4448-B300-41247E79719DQ35903107-F5A11230-B7EB-44EA-A75C-C8E1C2872014Q38528323-9B61E0C2-BAE3-494A-BBF9-4E8F9650FAA4Q38637362-C5E95212-BC3D-4B89-9CD4-62E41D224310Q38754342-DCAB4C0F-FEA0-4338-9F68-734325F1047DQ40555716-A18BB834-EC0D-4B2A-AEA5-BE22416FBB84Q40731460-36EF4A19-AC6A-422B-A758-75C4C8479459Q41531533-26BEABC9-69ED-405B-97D9-026478A9E978Q41632625-853FB372-1CB5-4FD7-A905-0C24630CDCE3Q45342464-23C27FAE-C859-4BF7-B7C7-ABB31C30FA08Q47675197-C1ACE685-E1E0-41B5-901A-C98411FA6BDEQ48785899-BC54E608-C8DC-4F1C-9881-FD28A9367D17Q50715033-82888427-78AC-4C5E-AE1B-24068E01D168Q50734529-61262B34-51EB-486F-8009-C057FE2CD676Q50738671-9F358E7B-3ACF-4B68-8617-4DBAFBA3066AQ50860371-798210C5-6DA4-4F5B-AE98-66A6D9B15920
P2860
DR(high+)CD45RA(-)-Tregs potentially affect the suppressive activity of the total Treg pool in renal transplant patients.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
DR
@nl
DR(high+)CD45RA(-)-Tregs poten ...... in renal transplant patients.
@ast
DR(high+)CD45RA(-)-Tregs poten ...... in renal transplant patients.
@en
type
label
DR
@nl
DR(high+)CD45RA(-)-Tregs poten ...... in renal transplant patients.
@ast
DR(high+)CD45RA(-)-Tregs poten ...... in renal transplant patients.
@en
prefLabel
DR
@nl
DR(high+)CD45RA(-)-Tregs poten ...... in renal transplant patients.
@ast
DR(high+)CD45RA(-)-Tregs poten ...... in renal transplant patients.
@en
P2093
P2860
P1433
P1476
DR(high+)CD45RA(-)-Tregs poten ...... in renal transplant patients.
@en
P2093
Andrea Steinborn
Edgar Schmitt
Friederike Hug
Martin Zeier
Nicole Seissler
Stefan Meuer
P2860
P304
P356
10.1371/JOURNAL.PONE.0034208
P407
P577
2012-03-28T00:00:00Z